Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring

[1]  J. Lundeberg,et al.  Toward Rare Blood Cell Preservation for RNA Sequencing. , 2015, The Journal of molecular diagnostics : JMD.

[2]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[3]  Cesar M. Castro,et al.  Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector , 2012, Science Translational Medicine.

[4]  R. Sandberg,et al.  Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.

[5]  Sridhar Ramaswamy,et al.  RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.

[6]  L. Ellis,et al.  A novel platform for detection of CK+ and CK- CTCs. , 2011, Cancer discovery.

[7]  L. V. van't Veer,et al.  A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer , 2011, British Journal of Cancer.

[8]  Fatima Sanchez-Cabo,et al.  Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients , 2010, BMC Cancer.

[9]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[10]  Jean Salamero,et al.  Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays , 2010, Proceedings of the National Academy of Sciences.

[11]  John A. Foekens,et al.  Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR , 2009, Breast Cancer Research and Treatment.

[12]  A. Oudenaarden,et al.  Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences , 2008, Cell.

[13]  L. J. Veer,et al.  Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells , 2008, Breast Cancer Research and Treatment.

[14]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[15]  T. Godfrey,et al.  Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. , 2007, Clinical chemistry.

[16]  Veit Zieglschmid,et al.  Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. , 2005, Anticancer research.

[17]  A. Chung,et al.  Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. , 2004, Biochemical and biophysical research communications.

[18]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[19]  I. Holen,et al.  The detection of circulating breast cancer cells in blood , 2004, Journal of Clinical Pathology.

[20]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[21]  M. Dowsett,et al.  Circulating tumour cells in breast cancer. , 2004, The Lancet. Oncology.

[22]  J. Schouten,et al.  Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. , 2003, Nucleic acids research.

[23]  C. Pilarsky,et al.  CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  A. Hart,et al.  Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients , 2003, British Journal of Cancer.

[25]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[27]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[28]  M. Campiglio,et al.  Role of HER2 gene overexpression in breast carcinoma , 2000, Journal of cellular physiology.

[29]  Keith R. Johnson,et al.  N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.

[30]  M. Reiss,et al.  Detection and viability of tumor cells in peripheral blood stem cell and bone marrow collections from breast cancer patients [letter; comment] , 1994 .

[31]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[32]  R. Butler,et al.  Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. , 1993, Cancer research.

[33]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.